¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"breast mass"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • effective mass
    À¯È¿Áú·®
  • electronic mass
    ÀüÀÚÁú·®
  • embryonic mass
    ¹è¾Æµ¢ÀÌ
  • echogenic mass
    ¸Þ¾Æ¸®¹ß»ýµ¢ÀÌ, ¿¡Äڹ߻ýÁ¾±«
  • equivalent mass
    µî°¡Áú·®
  • fat-free body mass
    Áö¹æÁ¦¿ÜüÁß
  • gravitational mass
    Áß·ÂÁú·®
  • inner cell mass
    ¼Ó¼¼Æ÷µ¢ÀÌ, ³»¼¼Æ÷±«
  • intermediate cell mass
    Áß°£¼¼Æ÷µ¢ÀÌ, Áß°£¼¼Æ÷±«
  • lateral mass
    °¡Âʵ¢ÀÌ
  • lean body mass
    Áö¹æ»«Ã¼Áß, ¸¶¸¥Ã¼Áß
  • mass
    1. µ¢ÀÌ, Á¾±« 2. Áý´Ü 3. Áú·®
  • mass action
    Áú·®ÀÛ¿ë
  • mass attenuation coefficient
    Áú·®°¨¼è°è¼ö
  • mass casualty incident
    ´ëÇüÀç³­»ç°í
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • charge to mass ratio
    ÀüÇÏ´ëÁú·®ºñ
  • cheesy mass
    °Ç¶ô¼ºµ¢ÀÌ
  • mass chemotherapy
    Áý´ÜÅõ¾à
  • mass consumption
    ´ë·®¼Òºñ
  • mass contraction
    Áý´Ü¼öÃà
  • mass attenuation coefficient
    Áú·®°¨¼è°è¼ö
  • mass energy absorption coefficient
    Áú·®¿¡³ÊÁöÈí¼ö°è¼ö
  • mass energy transfer coefficient
    Áú·®¿¡³ÊÁöÀüÀ̰è¼ö
  • selective mass chemotherapy
    ¾ç¼ºÀÚÁý´ÜÄ¡·á, ¾ç¼ºÀÚÁý´ÜÄ¡·á
  • mass disaster
    ´ëÇü»ç°í, Âü»ç
  • echogenic mass
    ¸Þ¾Æ¸®¹ß»ýµ¢ÀÌ, ¿¡Äڹ߻ýµ¢ÀÌ
  • effective mass
    À¯È¿Áú·®
  • electronic mass
    ÀüÀÚÁú·®
  • embryonic mass
    ¹è¾Æµ¢ÀÌ
  • equivalent mass
    µî°¡Áú·®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • breast,carcinoma lobular, in situ
    ¼Ò¿±¼º, ºñħÀ±¼º
  • breast,carcinoma mammography
    À¯¹æ Á¶¿µ¼ú (êáÛ®ðãç¯âú)
  • breast,carcinoma medullary
    ¼öÁú¼º (âÐòõàõ)
  • breast,carcinoma papillomatosis
    À¯µÎÁ¾Áõ (êáÔéðþñø)
  • breast,carcinoma scirrhous
    °æÁú¼º (Ìãòõàõ)
  • breast,cystic disease
    ³¶(Á¾)¼º Áúȯ (Ò¥ðþàõòðü´)
  • breast,cystic hyperplasia
    ³¶¼º Áõ½Ä (Ò¥àõñòãÖ)
  • breast,fibroadenoma
    ¼¶À¯¼±Á¾ (àéë«àÍðþ)
  • breast,fibrocystic disease
    ¼¶À¯ ³¶¼º Áúȯ(àéë«Ò¥àõòðü´)
  • breast,lactating adenoma
    À¯¼±Á¾(êáàÍðþ)
  • breast,mammary duct ectasia
    À¯°ü È®ÀåÁõ(êáηüªíåñø)
  • breast,mastitis
    À¯¼±¿° (êáàÍæú)
  • breast,sclerosing adenosis
    °æÈ­¼º ¼±Áõ (ÌãûùàõàÍñø)
  • breast,supernumeray nipple
    °úÀ× À¯µÎ(Φí¥êáÔé)
  • breast,traumatric fat necrosis
    ¿Ü»ó¼º Áö¹æ±«»ç (èâß¿àõò·Û¸ÎÕÞÝ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BCEI breast cancer estrogen-inducible
BCF basophil chemotactic factor; bioconcentration factor; breast cyst fluid
BCFP breast cyst fluid protein
BCPT breast cancer prevention trial
BCQ breast cancer questionnaire
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BSE Breast Self Examination
BCC Breast cancer cells
BCS Breast conservation surgery
BCT Breast conservation therapy
BCS Breast conserving surgery
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mass movement
    Áý´Ü ¿îµ¿
  • mass peristalsis
    Áý´Ü ¿¬µ¿, ´ë·® À̵¿¼º ¿¬µ¿
  • mass radiography apparatus
    Áý´Ü ¹æ»ç¼± ÃÔ¿µ ÀåÄ¡
  • mass spectrography
    Áú·® ºÐ±¤ °èÃø¹ý
  • mass susceptibility
    Áú·® ¹Î°¨µµ
  • mobile mass radiography stand
    À̵¿Çü Áý´Ü ¹æ»ç¼± ÃÔ¿µ´ë
  • polypoid mass
    Æú¸³¾ç Á¾±«
  • protruding lateral mass
    µ¹Ãâ Ãø¸é
  • sonolucent mass
    ÃÊÀ½ÆÄ Åõ°ú¼º Á¾±«
  • tissue mass
    Á¶Á÷ µ¢¾î¸®
  • tumor mass
    Á¾¾ç
  • virtual mass
    °¡»ó Áú·®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
genes, breast cancer susceptibility Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. Howeverm, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. See related entries to: BRCA1; BRCA2; Breast cancer, familial.
(12 Dec 1998)
chicken breast Pigeon-breasted.
(12 Dec 1998)
metastatic breast cancer Breast cancer that has spread to other parts of the body.
(16 Dec 1997)
circumscribed breast lesions <radiology> Lucent, lipoma, oil cyst (following haematoma or biopsy), galactocele (associated with lactation), mixed density, fibro-adeno-lipoma, galactocele, intramammary lymph node, haematoma
(12 Dec 1998)
coarse breast architecture <radiology> Inflammatory carcinoma, other lymphatic spread of tumour, oedema, congestive heart failure, uraemia, drug-induced, radiation, mastitis
(12 Dec 1998)
pigeon breast Prominence of the breast bone (sternum). Medically, pigeon breast is called pectus carinatum.
(12 Dec 1998)
cystic hyperplasia of the breast A benign disease common in women of the third, fourth, and fifth decades characterised by formation, in one or both breasts, of small cysts containing fluid which may appear as blue dome cysts; associated with stromal fibrosis and with variable degrees of intraductal epithelial hyperplasia and sclerosing adenosis.
Synonym: cystic hyperplasia of the breast.
(05 Mar 2000)
stellate breast lesions <radiology> Scirrhous carcinoma (infiltrating ductal carcinoma), small (baby) scirrhous carcinoma, sclerosing ductal hyperplasia, traumatic fat necrosis, hyalinised fibroadenoma
(12 Dec 1998)
supernumerary breast A milk-secreting gland located elsewhere than at the normal place on the chest and existing in addition to the two usual mammae.
Synonym: mamma accessoria, accessory breast, supernumerary mamma.
(05 Mar 2000)
suspensory ligaments of breast Well developed retinacula cutis that extend from the fibrous stroma of the mammary gland to the overlying skin.
Synonym: ligamenta suspensoria mammae, Cooper's ligaments, suspensory ligaments of Cooper.
(05 Mar 2000)
diameter at breast height The width of a plant stem (for example, tree trunk) as measured at 4.5 feet above the ground surface.
(09 Oct 1997)
irritable breast Swelling and induration of the breast, not due to a neoplasm, and usually of comparatively brief duration.
(05 Mar 2000)
thermography-breast A special infrared study which measures the skin temperature across the breasts. Used in the evaluation of breast abscess, breast cancer or another inflammatory process. This test is being replaced by breast ultrasound
(27 Sep 1997)
early stage breast cancer <oncology> Cancer is confined to the breast and has not spread to other sites in the body.
(16 Dec 1997)
familial breast cancer <oncology> A number of factors have been identified that increase the risk of breast cancer. One of the strongest of these risk factors is the history of breast cancer in a relative. About15-20% of women with breast cancer have such a family history of the disease, clearly reflecting the participation of inherited (genetic) components in the development of some breast cancers. Dominant breast cancer suceptibility genes, including BRCA1 and BRCA2, appear responsible for about 5% of all breast cancer. See related entries to: Breast cancer susceptibility genes; BRCA1; BRCA2.
There are 2 genes; BRCA1 and BRCA2 which are susceptibility genes for breast cancer. They are inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the li-fraumeni syndrome, cowden disease, muir-torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mass grave
    °øµ¿ ¹¦Áö (µ¿½Ã¿¡ ¸ÅÀåµÈ ¸¹Àº »ç¶÷µéÀÇ ¹¦Áö)
  • mass leave
    (Àεµ¿¡¼­ Ç×ÀÇÇϱâ À§ÇØ ¸¹Àº Á¾¾÷¿øÀÌ ÇÏ´Â) ÀÏÁ¦ ÈÞ°¡
  • mass man
    ´ëÁßÀû(Áý´Ü) Àΰ£ (´ëÁß »çȸ¸¦ ±¸¼ºÇÏ´Â °¡Á¤µÈ ÀüÇüÀû Àΰ£À¸·Î,°³¼ºÀÌ »ó½ÇµÊ)
  • mass media
    ´ëÁß Àü´Þ ±â°ü (¹æ¼Û,½Å¹®µî) (sing,mass medium)
  • mass medication
    (»ó¼öµµ¿¡ ¾à¹°À» ³Ö´Â ½ÄÀÇ) Áý´Ü Åõ¾à
  • mass meeting
    (ƯÈ÷ Á¤Ä¡Àû) ´ëÁß Áýȸ
  • mass metting
    (±¹¹Î) ´ëȸ
  • mass movement
    Áý´Ü À̵¿;´ëÁß ¿îµ¿
  • mass noun
    Áú·® ¸í»ç (uncountable ·Î¼­ ¹°Áú ¸í»ç¿Í Ãß»ó ¸í»ç¸¦ Æ÷ÇÔ)
  • mass number
    Áú·®¼ö(¿øÀÚÇÙ³»ÀÇ ¾çÀÚ¿Í Áß¼ºÀÚ¿ÍÀÇ ÃѼö,±âÈ£ A)
  • mass obervation
    ¿©·Ð Á¶»ç
  • mass priest
    ¹Ì»ç ¸Ã¾Æº¸´Â »çÁ¦;(°æ¸ê) Ä«Å縯 »çÁ¦
  • mass production
    ´ë·® »ý»ê 6
  • mass psychology
    ±ºÁß ½É¸®ÇÐ
  • mass ratio
    Áú·®ºñ (ÃßÁøºÎ¸¦ Á¦¿ÜÇÑ ·ÎÄÏ º»Ã¼¿¡ ´ëÇÑ ÃÑÁß·®ÀÇ ºñÀ²,ÃßÁø¾à ÃæÀüÀ²)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á